The role of dopamine in the modulation of monocyte-induced Th17- and Th1-immune response in multiple sclerosis
- 22 June 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 137, 112540
Abstract
No abstract availableKeywords
Funding Information
- Russian Science Foundation (22\u201375-10119)
This publication has 43 references indexed in Scilit:
- Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?Clinical & Translational Immunology, 2023
- High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple SclerosisCNS Drugs, 2022
- Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systemsNeurological Sciences, 2022
- Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk ManagementNeurotherapeutics, 2022
- The distinct roles of monoamines in multiple sclerosis: A bridge between the immune and nervous systems?Brain, Behavior, and Immunity, 2021
- Dopaminergic and Adrenergic Pathways as Targets for Drug Repurposing in the Neuroimmune NetworkJournal of Neuroimmune Pharmacology, 2020
- Dopaminergic Regulation of Innate Immunity: a ReviewJournal of Neuroimmune Pharmacology, 2017
- Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosisBrain, Behavior, and Immunity, 2014
- Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitisBiochemical and Biophysical Research Communications, 2008
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961